Bausch Health is up 7.4%, or 47c to $6.79.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BHC:
- Wells says a potential Bausch + Lomb sale would make sense given valuation
- Bausch + Lomb mulls sale, Financial Times reports
- Bausch Health announces Health Canada approval of CABTREO topical treatment
- Paulson buys Everbridge, cuts Anglogold in Q2
- Bausch’s eye-care spinoff plans stuck in standoff with creditors, WSJ reports